A Phase 1, Open Label, Fixed-Sequence Study To Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2010
At a glance
- Drugs Rifampicin; Tofacitinib
- Indications Plaque psoriasis; Psoriatic arthritis; Renal transplant rejection; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 21 Oct 2010 Actual end date (October 2010) added as reported by ClinicalTrials.gov.
- 21 Oct 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2010 New trial record